TCM
TCG Crossover Management Portfolio holdings
AUM
$876M
This Quarter Return
-4.16%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$249M
AUM Growth
+$249M
(+17%)
Cap. Flow
+$59.1M
Cap. Flow
% of AUM
23.74%
Top 10 Holdings %
Top 10 Hldgs %
78.83%
Holding
20
New
5
Increased
7
Reduced
2
Closed
–
Top Buys
| 1 |
Geron
GERN
|
$19.4M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$13.1M |
| 3 |
Tango Therapeutics
TNGX
|
$9.51M |
| 4 |
Kura Oncology
KURA
|
$8.14M |
| 5 |
Merus
MRUS
|
$1.98M |
Top Sells
| 1 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$1.22M |
| 2 |
Dianthus Therapeutics
DNTH
|
$284K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $42.4M | 17.01% |
2,516,920
+775,692
| +45% | +$13.1M |
|
2
Viridian Therapeutics
VRDN
$1.5B
| $24.3M | 9.75% |
1,314,000
| – | – |
|
3
Cogent Biosciences
COGT
$1.69B
| $22.3M | 8.96% |
2,981,042
+231,005
| +8% | +$1.73M |
|
4
Aclaris Therapeutics
ACRS
$209M
| $19.7M | 7.92% |
1,144,939
+62,726
| +6% | +$1.08M |
|
|
5
Geron
GERN
$893M
| $19.4M | 7.8% |
+14,285,715
| New | +$19.4M |
|
|
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
| $18.4M | 7.37% |
5,905,400
| – | – |
|
|
JBIO
7
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $16.3M | 6.55% |
889,572
+36,242
| +4% | +$664K |
|
|
KDNY
8
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $14.4M | 5.79% |
882,353
| – | – |
|
9
Tyra Biosciences
TYRA
$675M
| $9.59M | 3.85% |
896,418
+45,968
| +5% | +$492K |
|
|
10
Tango Therapeutics
TNGX
$747M
| $9.51M | 3.82% |
+1,254,500
| New | +$9.51M |
|
|
ALPN
11
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $9.28M | 3.72% |
1,034,222
-135,990
| -12% | -$1.22M |
|
|
12
Kura Oncology
KURA
$686M
| $8.14M | 3.27% |
+506,423
| New | +$8.14M |
|
|
13
Merus
MRUS
$4.98B
| $7.93M | 3.18% |
300,000
+75,000
| +33% | +$1.98M |
|
|
AKUS
14
DELISTED
Akouos, Inc. Common Stock
AKUS
| $6.41M | 2.57% |
1,350,006
+304,791
| +29% | +$1.45M |
|
|
15
Dianthus Therapeutics
DNTH
$759M
| $6.16M | 2.47% |
2,124,122
-98,100
| -4% | -$284K |
|
16
Entrada Therapeutics
TRDA
$208M
| $6.13M | 2.46% |
663,694
| – | – |
|
17
Zai Lab
ZLAB
$3.68B
| $4.18M | 1.68% |
95,000
| – | – |
|
|
PRDS
18
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $1.65M | 0.66% |
+229,100
| New | +$1.65M |
|
19
AnaptysBio
ANAB
$569M
| $1.45M | 0.58% |
+58,515
| New | +$1.45M |
|
|
ELEV
20
DELISTED
Elevation Oncology
ELEV
| $1.4M | 0.56% |
555,000
| – | – |
|